in patients with poor metabolic control ( n = 11 ; 6 female , 5 male ; age 25 +/- 5 sd years ; hba1c 10.7 +/- 0.9 ) prekallikrein ( p less than 0.05 ) , kallikrein inhibitor ( p less than 0.005 ) and alpha-2-macroglobulin ( p less than 0.005 ) were significantly elevated compared to the controls .
C0033024
prekallikrein
C0022478
kallikrein